Breaking News Instant updates and real-time market news.

LGND

Ligand

$97.32

-1.22 (-1.24%)

18:19
10/07/16
10/07
18:19
10/07/16
18:19

Ligand partner Lundbeck announces FDA approval of Carnexiv injection

Ligand Pharmaceuticals partner Lundbeck announced today that the U.S. FDA has approved Carnexiv injection as a short-term replacement therapy for oral carbamazepine formulations in adults with certain seizure types when oral administration is temporarily not feasible. Carnexiv received orphan drug designation for this indication and will be the first available intravenous formulation of the antiepileptic drug carbamazepine. Lundbeck plans to make Carnexiv commercially available in the United States in early 2017. With the approval, Ligand has earned a $1.25M milestone payment. Ligand is also entitled to receive a royalty of 2.75% on net sales of Carnexiv.

LGND Ligand
$97.32

-1.22 (-1.24%)

09/07/16
ROTH
09/07/16
NO CHANGE
Target $149
ROTH
Buy
Ligand has 'major catalyst' ahead, says Roth Capital
Roth Capital analyst Joseph Pantginis says Ligand (LGND) is expecting a "major catalyst" this month namely the Phase IIb sparsentan data in focal segmental glomerulosclerosis patients being developed by partner Retrophin (RTRX). In a separate note to investors, Pantginis also said that the Breakthrough Therapy Designation of SAGE Therapeutics' (SAGE) '547 for postpartum depression may expedite its development and approval for use in the clinic, noting that the company has an agreement of 3% royalty payment to Ligand for potential sales of the drug. The analyst recommends steady accumulation of Ligand's stock as he anticipates that current revenue streams from partnered products and the broad "in development" portfolio are poised to drive significant growth in the near and longer term. He reiterates a Buy rating and $149 price target on Ligand's shares.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $151
ROTH
Buy
Ligand target raised to $151 after sparsentan data at Roth Capital
Roth Capital analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals (LGND) to $151 from $149 after the company's partner Retrophin (RTRX) announced positive data from the sparsentan Phase II study in focal segmental glomerulosclerosis patients. The analyst believes the data support a potential accelerated path forward and he reminds investors that FSGS has no approved therapies. Pantginis calls the data an important win for Ligand and Retrophin. He keeps a Buy rating on Ligand. The stock is up 7% to $115.21 in early trading.
09/07/16
09/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Hold from Underperform at Jefferies with analyst Jason Gammel citing valuation and improving financial metrics. 2. DineEquity (DIN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull saying the stock has reached a good entry point, while its risk/reward ratio is "compelling." 3. Gaming and Leisure Properties (GLPI) upgraded to Overweight at Morgan Stanley. 4. Aviva (AV) upgraded to Buy from Neutral at UBS with the firm saying the company is positioned to be the risk-adjusted dividend leader in the sector. 5. Ligand (LGND) upgraded to Hold from Sell at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
HCWC
10/05/16
NO CHANGE
Target $160
HCWC
Buy
Ligand price target raised to $160 from $146 at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther raised her price target for Ligand Pharmaceuticals to $160 citing three recent positive events, namely positive Phase II focal segmental glomerulosclerosis data from partner Retrophin, the beginning of a Phase II clinical trial with LGD-6972 for the treatment of type 2 diabetes and the licensing of several therapeutic programs to Seelos. Werther keeps a Buy rating on Ligand.

TODAY'S FREE FLY STORIES

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

CSCO

Cisco

$34.26

-0.06 (-0.17%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Cisco to host service provider tech talk »

Cisco SVP Kanouff hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 03

    Mar

AQMS

Aqua Metals

$16.38

-0.33 (-1.97%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Aqua Metals management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

WSTC

West Corp.

$24.37

0.01 (0.04%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
West Corp. to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

MRCY

Mercury Systems

$37.94

0.35 (0.93%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Mercury Systems management to meet with Drexel Hamilton »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TRNO

Terreno Realty

$28.07

0.04 (0.14%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Terreno Realty management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

WDFC

WD-40

$111.25

1.5 (1.37%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
WD-40 management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

AAN

Aaron's

$27.34

0.16 (0.59%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Aaron's management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

IT

Gartner

$104.55

0.84 (0.81%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Gartner managment to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Jun

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

Pres. Donald Trump Speech…

EFX

Equifax

$130.81

1.43 (1.11%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Equifax to hold a webcast »

Equifax Senior Vice…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 02

    Mar

  • 02

    Mar

HCKT

Hackett Group

$20.13

0.12 (0.60%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Hackett Group management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    Mar

DLA

Delta Apparel

$18.03

0.37 (2.10%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Delta Apparel management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

LPCN

Lipocine

$4.01

0.15 (3.89%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Lipocine management to meet with Roth Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 21

    Mar

SRC

Spirit Realty

$11.07

0.08 (0.73%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Spirit Realty management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

VRTU

Virtusa

$30.49

2.14 (7.55%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Virtusa management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

  • 16

    Mar

  • 21

    Mar

  • 22

    Mar

  • 27

    Mar

  • 28

    Mar

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

St. Louis Federal Reserve…

04:55
02/28/17
02/28
04:55
02/28/17
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

TRIP

TripAdvisor

$42.81

0.19 (0.45%)

, SPLK

Splunk

$62.62

-0.18 (-0.29%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Morgan Stanley to hold a conference »

Technology, Media &…

TRIP

TripAdvisor

$42.81

0.19 (0.45%)

SPLK

Splunk

$62.62

-0.18 (-0.29%)

CBS

CBS

$66.23

-0.74 (-1.11%)

NTAP

NetApp

$41.27

0.32 (0.78%)

GRPN

Groupon

$4.49

0.02 (0.45%)

AMT

American Tower

$113.34

0.45 (0.40%)

CA

CA Technologies

$32.57

-0.06 (-0.18%)

TRUE

TrueCar

$14.41

0.13 (0.91%)

TNET

TriNet

$27.13

0.55 (2.07%)

STX

Seagate

$47.69

-0.06 (-0.13%)

VIA

Viacom

$46.05

-0.6 (-1.29%)

NVDA

NVIDIA

$104.41

2.95 (2.91%)

CTL

CenturyLink

$24.61

0.03 (0.12%)

SIRI

Sirius XM

$5.18

0.06 (1.17%)

MXIM

Maxim Integrated

$44.96

-0.1 (-0.22%)

CSOD

Cornerstone OnDemand

$42.65

0.4 (0.95%)

TEAM

Atlassian

$28.82

-0.45 (-1.54%)

WDC

Western Digital

$76.10

1.45 (1.94%)

YELP

Yelp

$34.07

0.61 (1.82%)

EGHT

8x8, Inc.

$15.65

-0.5 (-3.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 05

    Mar

  • 06

    Mar

  • 08

    Mar

  • 08

    Mar

  • 13

    Mar

  • 14

    Mar

  • 16

    Mar

  • 19

    Mar

  • 20

    Mar

  • 22

    Mar

  • 23

    Mar

JBHT

J.B. Hunt

$100.12

0.3 (0.30%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
J.B. Hunt management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 05

    Mar

  • 28

    Mar

VAC

Marriott Vacations

$96.62

-2.28 (-2.31%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Marriott Vacations management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

NURO

NeuroMetrix

$0.64

0.0087 (1.38%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
NeuroMetrix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TGT

Target

$66.91

0.4 (0.60%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Target to hold a financial community meeting »

Management holds 2017…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 19

    Mar

LIOX

Lionbridge

$5.75

0.01 (0.17%)

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
Lionbridge to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

04:55
02/28/17
02/28
04:55
02/28/17
04:55
Conference/Events
JPMorgan to hold a conference »

Global Emerging Markets…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.